Cancer stem-like cells of head and neck squamous cell carcinoma (HNSCC) that survive treatment with cetuximab, an epidermal growth factor receptor (EGFR)-targeting agent, are sensitive to the induction of ferroptosis by SSZ [38,39]. Here, EGFR is linked to cancer.